The Scope of HbA1c Variability and Risk of Vascular Complications Among Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Studies
Authors:
- 7 February 2022
- journal article
- review article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 54 (02) , 94-103
Abstract
Glycated hemoglobin (HbA1c) variability is emerging as an indicator of long-term glycemic control, which may play a significant role during vascular complications. We conducted a systematic review and meta-analysis to assess the association between the scope of HbA1c variability and vascular complications in patients with type 2 diabetes mellitus. PubMed and Embase were searched for studies that evaluated the association of HbA1c variability with vascular complications in patients with type 2 diabetes. Two reviewers independently completed data extraction. Random-effects meta-analysis was conducted with stratification according to the type of vascular complications. Nine studies were eligible for inclusion in our systematic review and meta-analysis. Six studies evaluated the impact of the standard deviation of HbA1c (HbA1c-SD) on cardiovascular events and showed an association of HbA1c-SD with cardiovascular events (HR: 1.25, 95% CI 1.18–1.32, 5 studies). Six studies evaluated renal disease associated with HbA1c-SD and showed that HbA1c-SD was correlated with an increased risk of renal disease (HR: 1.19, 95% CI 1.13–1.24). Two studies evaluated HbA1c-SD and the risk of retinopathy and showed that no significant association was found between retinopathy and HbA1c-SD (HR 1.08, 95% CI 0.92–125). For HbA1c-SD ranging from 0.6 to 0.8%, HbA1c-SD was associated with an increased risk of cardiovascular events (HR: 1.25, 95% CI 1.15–1.35) and renal disease (HR: 1.16, 95% CI 1.11–1.22). For individuals with index HbA1c variability greater than or equal to 0.6%, HbA1c variability was significantly associated with vascular complications in patients with type 2 diabetes mellitus.Keywords
Funding Information
- Certificate of China Postdoctoral Science Foundation (2019M651970)
- Natural Science Foundation of the Jiangsu Higher Education Institution of China (17KJD310005)
- Jiangsu Province graduate student innovation project (KYCX19-2214)
- Xuzhou Medical University Research Project (2017KJ03)
This publication has 41 references indexed in Scilit:
- Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE TrialDiabetes Care, 2014
- HbA1c Variability as an Independent Risk Factor for Diabetic Retinopathy in Type 1 Diabetes: A German/Austrian Multicenter Analysis on 35,891 PatientsPLOS ONE, 2014
- Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter StudyCardiovascular Diabetology, 2013
- Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes RegistryDiabetes/Metabolism Research and Reviews, 2013
- HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort studyDiabetologia, 2012
- Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type 2 diabetesDiabetic Medicine, 2012
- HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2Diabetologia, 2012
- A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 DiabetesDiabetes Care, 2011
- Geographic Variation in Diagnosis Frequency and Risk of Death Among Medicare BeneficiariesJAMA, 2011
- ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care settingDiabetic Medicine, 2010